Cart
sales@molnova.com
CB1R antagonist 1
CAS No. 334668-69-8
CB1R antagonist 1( —— )
Catalog No. M35611 CAS No. 334668-69-8
CB1R antagonist 1 is a potent CB1R antagonist that can be used to study diseases related to the nervous system.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 65 | In Stock |
|
| 10MG | 112 | In Stock |
|
| 25MG | 188 | In Stock |
|
| 50MG | 272 | In Stock |
|
| 100MG | 407 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCB1R antagonist 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionCB1R antagonist 1 is a potent CB1R antagonist that can be used to study diseases related to the nervous system.
-
DescriptionCB1R Allosteric modulator 5, a selective cannabinoid-1 receptor (CB1R) inverse agonist with an IC50 value of 4.2 μM and EC50 value of ＞10 μM. CB1R Allosteric modulator 5 can be used for the research of metabolic and obesity.
-
In VitroCB1R Allosteric modulator 5 has cannabinoid-1 receptor (CB1R) activity with an IC50value of 4.2 μM and EC50 value of ＞10 μM.
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number334668-69-8
-
Formula Weight404.45
-
Molecular FormulaC18H23F3N2O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (247.25 mM; Ultrasonic )
-
SMILESS(=O)(=O)(C1=CC(C(F)(F)F)=CC=C1)N2CCN(C(=O)C3CCCCC3)CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Petr Vachal, et al. 1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity. J Med Chem. 2009 Apr 23;52(8):2550-8?
molnova catalog
related products
-
Rimonabant hydrochlo...
Rimonabant Hcl(SR141716A) is a selective central cannabinoid (CB1) receptor inverse agonist with Ki of 1.8 nM.
-
VCE-004.3
VCE-004.3 (VCE004.3) is a novel semi-synthetic cannabidiol derivative behaving as a dual PPARγ/CB2 agonist and CB1 receptor modulator.
-
AM-1221
A potent and selective agonist for the cannabinoid receptor CB1 with Ki of 0.28 nM, 180-fold selectivity over CB2.
